Literature DB >> 18829757

Excretion of human immunodeficiency virus type 1 through polarized epithelium by immunoglobulin A.

Alison Wright1, Michael E Lamm, Yung T Huang.   

Abstract

Human immunodeficiency virus (HIV) is transmitted primarily sexually across mucosal surfaces. After infection, HIV propagates initially in the lamina propria below the polarized epithelium and causes extensive destruction of mucosal T cells. Immunoglobulin A (IgA) antibodies, produced in the lamina propria and then transcytosed across the mucosal epithelium into the lumen, can be the first line of immune defense against HIV. Here, we used IgA monoclonal antibodies against HIV envelope proteins to investigate the abilities of polarized primate and human epithelial cells to excrete HIV virions from the basolateral to the apical surface via polymeric Ig receptor (pIgR)-mediated binding and the internalization of HIV-IgA immune complexes. African green monkey kidney cells expressing pIgR demonstrated HIV excretion that was dependent on the IgA concentration and the exposure time. Matched IgG antibodies with the same variable regions as the IgA antibodies and IgA antibodies to non-HIV antigens had no HIV excretory function. A mixture of two IgA anti-bodies against gp120 and gp41 showed a synergistic increase in the level of HIV excreted. The capacity for HIV excretion correlated with the ability of IgA antibodies to bind HIV and of the resulting immune complexes to bind pIgR. Consistent with the epithelial transcytosis of HIV-IgA immune complexes, the colocalization of HIV proteins and HIV-specific IgA was detected intracellularly by confocal microscopy. Our results suggest the potential of IgA antibodies to excrete HIV from mucosal lamina propria, thereby decreasing the viral burden, access to susceptible cells, and the chronic activation of the immune system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18829757      PMCID: PMC2583660          DOI: 10.1128/JVI.01111-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  80 in total

1.  Primary intestinal epithelial cells selectively transfer R5 HIV-1 to CCR5+ cells.

Authors:  Gang Meng; Xiping Wei; Xiaoyun Wu; Marty T Sellers; Julie M Decker; Zina Moldoveanu; Jan M Orenstein; Martin F Graham; John C Kappes; Jiri Mestecky; George M Shaw; Phillip D Smith
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

2.  Cell-associated HIV-1 infection of salivary gland epithelial cell lines.

Authors:  Jennifer S Moore; Stacy D Hall; Susan Jackson
Journal:  Virology       Date:  2002-05-25       Impact factor: 3.616

3.  Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model.

Authors:  Huimin Yan; Michael E Lamm; Ewa Björling; Yung T Huang
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

4.  Opsonization of HIV-1 by semen complement enhances infection of human epithelial cells.

Authors:  Hicham Bouhlal; Nicolas Chomont; Nicole Haeffner-Cavaillon; Michel D Kazatchkine; Laurent Belec; Hakim Hocini
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

Review 5.  The role of mucosal immunity in prevention of HIV transmission.

Authors:  Pamela A Kozlowski; Marian R Neutra
Journal:  Curr Mol Med       Date:  2003-05       Impact factor: 2.222

6.  Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb.

Authors:  Ningguo Feng; Jeffrey A Lawton; Joana Gilbert; Nelly Kuklin; Phuoc Vo; B V Venkataram Prasad; Harry B Greenberg
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

7.  Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women.

Authors:  L Bélec; P D Ghys; H Hocini; J N Nkengasong; J Tranchot-Diallo; M O Diallo; V Ettiègne-Traore; C Maurice; P Becquart; M Matta; A Si-Mohamed; N Chomont; I M Coulibaly; S Z Wiktor; M D Kazatchkine
Journal:  J Infect Dis       Date:  2001-11-13       Impact factor: 5.226

8.  Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.

Authors:  Claudia Devito; Jorma Hinkula; Rupert Kaul; Joshua Kimani; Peter Kiama; Lucia Lopalco; Claudia Barass; Stefania Piconi; Daria Trabattoni; Job J Bwayo; Francis Plummer; Mario Clerici; Kristina Broliden
Journal:  J Acquir Immune Defic Syndr       Date:  2002-08-01       Impact factor: 3.731

9.  Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins.

Authors:  Isabelle Schwartz-Cornil; Yann Benureau; Harry Greenberg; Barbara A Hendrickson; Jean Cohen
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

10.  Characterization of human class-switched polymeric (immunoglobulin M [IgM] and IgA) anti-human immunodeficiency virus type 1 antibodies 2F5 and 2G12.

Authors:  Susanne Wolbank; Renate Kunert; Gabriela Stiegler; Hermann Katinger
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

View more
  14 in total

Review 1.  The role of secretory antibodies in infection immunity.

Authors:  Richard A Strugnell; Odilia L C Wijburg
Journal:  Nat Rev Microbiol       Date:  2010-08-09       Impact factor: 60.633

2.  Systemic and mucosal differences in HIV burden, immune, and therapeutic responses.

Authors:  Sharon M Wahl; Maryann Redford; Shawna Christensen; Wendy Mack; Jon Cohn; Edward N Janoff; Jiri Mestecky; Hal B Jenson; Mahvash Navazesh; Mardge Cohen; Patricia Reichelderfer; Andrea Kovacs
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04-15       Impact factor: 3.731

3.  Humoral immunogenicity of an HIV-1 envelope residue 649-684 membrane-proximal region peptide fused to the plague antigen F1-V.

Authors:  Nobuyuki Matoba; Namrata Rahul Shah; Tsafrir S Mor
Journal:  Vaccine       Date:  2011-07-13       Impact factor: 3.641

4.  Inhibitory effect of HIV-specific neutralizing IgA on mucosal transmission of HIV in humanized mice.

Authors:  Eun Mi Hur; Sonal N Patel; Saki Shimizu; Dinesh S Rao; Priyanthi N P Gnanapragasam; Dong Sung An; Lili Yang; David Baltimore
Journal:  Blood       Date:  2012-10-11       Impact factor: 22.113

Review 5.  Humoral immune responses to HIV in the mucosal secretions and sera of HIV-infected women.

Authors:  Jiri Mestecky; Qing Wei; Rashada Alexander; Milan Raska; Jan Novak; Zina Moldoveanu
Journal:  Am J Reprod Immunol       Date:  2014-02-05       Impact factor: 3.886

Review 6.  Engineering broadly neutralizing antibodies for HIV prevention and therapy.

Authors:  Casey K Hua; Margaret E Ackerman
Journal:  Adv Drug Deliv Rev       Date:  2016-01-29       Impact factor: 15.470

Review 7.  Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV.

Authors:  Deborah J Anderson; Joseph A Politch; Larry Zeitlin; Andy Hiatt; Kadryn Kadasia; Kenneth H Mayer; Ruth M Ruprecht; Francois Villinger; Kevin J Whaley
Journal:  AIDS       Date:  2017-07-17       Impact factor: 4.632

8.  The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells.

Authors:  Sandeep Gupta; Johannes S Gach; Juan C Becerra; Tran B Phan; Jeffrey Pudney; Zina Moldoveanu; Sarah B Joseph; Gary Landucci; Medalyn Jude Supnet; Li-Hua Ping; Davide Corti; Brian Moldt; Zdenek Hel; Antonio Lanzavecchia; Ruth M Ruprecht; Dennis R Burton; Jiri Mestecky; Deborah J Anderson; Donald N Forthal
Journal:  PLoS Pathog       Date:  2013-11-21       Impact factor: 6.823

Review 9.  Are anti-HIV IgAs good guys or bad guys?

Authors:  Mingkui Zhou; Ruth M Ruprecht
Journal:  Retrovirology       Date:  2014-12-14       Impact factor: 4.602

Review 10.  The Role of the Polymeric Immunoglobulin Receptor and Secretory Immunoglobulins during Mucosal Infection and Immunity.

Authors:  Holly Turula; Christiane E Wobus
Journal:  Viruses       Date:  2018-05-03       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.